Revvity (NYSE:RVTY) Upgraded by Wall Street Zen to "Buy" Rating

Key Points

• Wall Street Zen upgraded Revvity from “hold” to “buy,” although broader analyst sentiment remains cautious, with a consensus “hold” rating and average price target of $108.36.
• Revvity’s shares opened at $114.81, near their 52-week high of $118.30. The stock trades at a relatively high P/E ratio of 54.67 and has a market capitalization of $12.81 billion.
• The company exceeded quarterly expectations, reporting adjusted EPS of $1.41 versus the $1.21 consensus and revenue of $711 million, though sales declined 1.3% year over year. Institutional investors own 86.65% of the stock.

Revvity (NYSE:RVTY - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Saturday.

Several other research firms have also recently commented on RVTY. Weiss Ratings upgraded Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th. Barclays boosted their target price on shares of Revvity from $95.00 to $105.00 and gave the company an "equal weight" rating in a report on Thursday, May 7th. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $96.00 to $90.00 and set a "neutral" rating on the stock in a report on Wednesday, May 6th. Evercore reissued an "outperform" rating on shares of Revvity in a research note on Wednesday. Finally, Stifel Nicolaus cut their target price on Revvity from $110.00 to $100.00 and set a "hold" rating on the stock in a research report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, Revvity presently has an average rating of "Hold" and a consensus price target of $108.36.

Revvity Stock Up 0.5%

RVTY stock opened at $114.81 on Friday. The company has a 50 day moving average price of $108.01 and a two-hundred day moving average price of $100.03. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.41 and a current ratio of 1.80. The stock has a market capitalization of $12.81 billion, a P/E ratio of 54.67, a PEG ratio of 2.08 and a beta of 1.07. Revvity has a one year low of $81.22 and a one year high of $118.30.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.20. The business had revenue of $711.00 million for the quarter, compared to analysts' expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business's revenue was down 1.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, sell-side analysts expect that Revvity will post 5.35 EPS for the current year.

Institutional Trading of Revvity

Several large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in Revvity in the 2nd quarter worth approximately $852,070,000. Norges Bank purchased a new stake in shares of Revvity during the fourth quarter valued at approximately $80,382,000. Bank of New York Mellon Corp acquired a new position in shares of Revvity during the second quarter worth $78,766,000. Morgan Stanley lifted its position in shares of Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company's stock worth $275,202,000 after purchasing an additional 650,083 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of Revvity by 7.0% in the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company's stock valued at $789,595,000 after purchasing an additional 533,912 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source